A new criteria for screening macroprolactinemia using polyethylene glycol treatment combined with different assays for prolactin.
To establish the criteria for screening macroprolactinemia (MP) after Polyethylene glycol (PEG) treatment plus different assays of Prolactin (PRL) in a clinical setting. This study recruited 122 patients, and their PRL-elevated serum samples were collected. Twenty-two of the 122 serum samples were treated by gel filtration chromatography (GFC) and PEG precipitation. The PRL content in the eluent and supernatant were tested separately by two analyzers: i2000sr (Abbott Laboratories, Chicago, IL, USA) and E170 (Roche Diagnostics, Basel, Switzerland). The GFC-method (the gold standard) was applied, in order to establish the criteria of screening MP after PEG-method. The MP positive rate and PRL concentrations in 100 PRL-elevated patients were compared between the literature criteria (a PRL recovery of < 40%) and the new criteria. The detected value of macroprolactin with the new criteria in the i2000sr (a PRL recovery of < 50%) was higher than in the E170 (a PRL recovery of < 60%). The E170 analyzer detected 38 cases of MP in 100 PRL-elevated samples by using new criteria, which was higher than the literature criteria (24 cases) (p < 0.05). Therefore, there were 15 samples could not be judged consistently using the literature criteria by the i2000sr and E170 analyzers. There was also a significant difference in PRL concentrations between the two groups (p < 0.01). If using the new criteria, the inconsistency between the two analyzers was reduced to 2 samples. There was a very significant difference in the inconsistency between two criteria (p < 0.01). The reported values of PRL from the i2000sr and E170 were 27.8 (16.2-42.6) ng/ml and 32.0 (19.6-49.9) ng/ml. There were no significant differences between two analyzers. Establishment of different criteria for screening MP by using PEG-method is helpful for the accuracy of PRL determination and its comparability.